Siemens Siemens.com Siemens diagnostics.com
Search Our Knowledge Base
Physicians Laboratory Professionals Healthcare Administrators Patients
 
Home



hsCRP

Citations are listed in chronological order.

1. Kereiakes D. The fire that burns within: C-reactive protein. Circulation . 2003; 107: 373-374.
2. Pearson T, Mensah G, Alexander R, et al. Markers of inflammation and cardiovascular disease: Application to clinical and public health practice. Circulation . 2003; 107: 499-511.
3. Ridker P. Clinical application of C-reactive protein for cardiovascular disease detection and prevention. Circulation . 2003; 107: 363-369.
4. Ridker PM, Buring JE, Cool NR, Rifai N. C-reactive protein, the metabolic syndrome, and risk of incident cardiovascular events. Circulation. 2003; 107: 391-397.
5. Yeh ETH, Willerson JT. Coming of age of C-reactive protein: Circulation . 2003; 107: 370-372.
6. Meier-Ewert HK, Ridker PM, Rifai N, et al. Absence of diurnal variation of C-reactive protein concentrations in healthy human subjects. Clin Chem . 2001; 47(3): 426-430.

7

Ockene IS, Matthews CE, Rifai N, et al. Variability and classification accuracy of serial high-sensitivity C-reactive protein measurements in healthy adults. Clin Chem . 2001; 47(3): 444-450.

8

Rifai N, Ridker P. High-sensitivity C-reactive protein: a novel and promising marker of coronary heart disease. Clin Chem . 2001; 47(3): 403-411.
9. Roberts WL, Moulton L, Law TC, et al. Evaluation of nine automated high-sensitivity C-reactive protein methods: Implications for clinical and epidemiological applications, part 2. Clin Chem. 2001; 47(3): 418-425.
10. Duncan BH, Heller GV. Acute rest myocardial perfusion imaging in the evaluation of patients with chest pain syndromes. ACC Current Journal Review. 1999; 8: 52 -56.
11. Morrow DA, Ridker PM. High sensitivity C-Reactive Protein (hsCRP): A novel risk marker in cardiovascular disease. Prev Cardiol . 1999; Winter: 13-16, 41.
12. Ridker PM. Evaluating novel cardiovascular risk factors: Can we better predict heart attacks? Ann Intern Med. 1999; 130: 933-937.
13. Stefanadis C, Diamantopoulos L, Vlachopoulos C, Tsiamis E, Dernellis J, Toutouzas K, et al. Thermal heterogeneity within human atherosclerotic coronary arteries detected in vivo . Circulation. 1999; 99: 1965-1970.
14. Morrow D, Rifai N, Antman E, et al. C-reactive protein is a potent predictor of mortality independently and in combination with troponin T in acute coronary syndromes. J Am Coll Cardiol. 1998; 31: 1460-1465.
15. Ridker PM, Buring JE, Shih J, Matias M, Hennekens CH. Prospective study of C-reactive protein and the risk of future cardiovascular events among apparently healthy women. Circulation. 1998; 98:731-733.
16. Ridker PM, Cushman M, Stampfer MJ, Tracy RP, Hennekens CH. Plasma concentration of C-reactive protein and risk of developing peripheral vascular disease. Circulation. 1998; 97: 425-428.
17. Ridker PM, Glynn RJ, Hennekens CH. C-reactive protein adds to the predictive value of total and HDL cholesterol in determining risk of first myocardial infarction. Circulation. 1998; 97: 2007-2011.
18. Ridker PM, Haughie P. Prospective studies of C-reactive protein as a risk factor for cardiovascular disease. J Investig Med. 1998; 46: 391-395.
19. Tracy, RP. C-reactive protein and cardiovascular disease. Clinl Lab News. 1998; 24: 14-16.
20. Koenig W, Froehlich M, Sund M, et al. C-reactive protein predicts risk of coronary heart disease in middle-aged men: Results from the MONICA-Augsberg Cohort Study. Circulation. 1997; 89: 36-44.
21. Macy EM, Hayes TE, Tracy RP. Variability in the measurement of C-reactive protein in healthy subjects: Implications of reference intervals and epidemiological applications. Clin Chem . 1997; 43: 52-58.
22. Ridker PM, Cushman M, Stampfer MJ, Tracy RP, Hennekens CH. Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men. N Engl J Med . 1997; 336: 973-979.
23. Heinrich J, Schulte H, Schönfeld R, Köhler E, Assmann G. Association of variables of coagulation, fibrinolysis and acute-phase with atherosclerosis in coronary and peripheral arteries and those arteries supplying the brain. Thromb Haemost. 1995; 73: 374-379.

Back to Recommended Readings

© Siemens Healthcare Diagnostics Inc. 2007-2008 | Corporate Information | Privacy Policy | Terms of Use | Home | What's New | Glossary | Contact Us | Site Map | Site Index